Jose Manuel Celaya Velazquez
About Jose Manuel Celaya Velazquez
Jose Manuel Celaya Velazquez is the Country Medical Director at Bristol Myers Squibb in México, with extensive experience in various roles within the pharmaceutical industry.
Title and Current Position
Jose Manuel Celaya Velazquez holds the position of Country Medical Director at Bristol Myers Squibb in México. He oversees various medical affairs for the company within the country, focusing on strategic leadership in medical activities and compliance.
Professional Experience at Bristol Myers Squibb
Jose Manuel Celaya Velazquez has held multiple roles at Bristol Myers Squibb. From 2019 to 2020, he worked as Disease Area Specialist Oncology / Hematology / Innovative Medicines for Mexico. Between 2017 and 2018, he served as Disease Area Specialist Hematology and Immunology NORTH HUB. Prior to these roles, from 2015 to 2017, he was a Scientific Advisor for Hepatitis C and Hematology.
Previous Roles in the Pharmaceutical Industry
Jose Manuel Celaya Velazquez has amassed extensive experience in the pharmaceutical sector. From 2013 to 2015, he worked as Gerente Médico Oncología at Roche in Lomas de Chapultepec. He was with Novartis from 2011 to 2013 as a Local Medical Affairs and Clinical Trial Leader in Metabolism and earlier from 2006 to 2008 as Gerente Médico Senior y Sci Ops Head. His career also includes a three-year tenure at Janssen-Cilag as Gerente Médico de Grupo from 2008 to 2011.
Educational Background
Jose Manuel Celaya Velazquez studied at Universidad Nacional Autónoma de México where he focused on Área Médica and earned the title Médico Internista from 1994 to 2004. He completed a six-year study program at the same institution from 1994 to 2000.
Expertise and Specializations
Jose Manuel Celaya Velazquez has expertise in leading start-up projects for Local Clinical Research, particularly in Phase 3b and Phase 4 trials. He has developed and implemented Medical Science Liaison (MSL) strategies, Continuing Medical Education (CME), and compliance strategies for the pharmaceutical industry. He supports Medical Marketing, Access, Clinical Operations, and Regulatory-Pharmacovigilance teams in submission, approval, and launch of clinical trials and new products. His specialized knowledge spans multiple therapeutic areas including Diabetes, Cardiovascular, Oncology, Immunology, Anti-infectives, Anti-psychotics, and Sexual and Women's Health.